Catheter-related Staphylococcus aureus bacteremia in cancer patients: High rate of complications with therapeutic implications

Medicine

Volumn 86, Issue 1, 2007, Pages 54-60

  Ghanem, Ghazi A ^a   Boktour, Maha ^a   Warneke, Carla ^a   Pham Williams, Trang ^a   Kassis, Christelle ^b   Bahna, Paul ^a   Aboufaycal, Halim ^a   Hachem, Ray ^a   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ABSCESS; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; CANCER PATIENT; CATHETER INFECTION; CLINICAL FEATURE; CONFIDENCE INTERVAL; DEATH; DEMOGRAPHY; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; KIDNEY FAILURE; LABORATORY TEST; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OSTEOMYELITIS; PATIENT CODING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33846219966     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e318030d344     Document Type: Review

References (28)

1. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother. 1998;42:3169-3172.
2. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost. 1992;18:353-372.
3. Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, Bastuji-Garin S. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis. 2003;36:149-158.
4. De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res. 1997;86:101-113.
5. Del Favero A, Menichetti F, Martino P, Bucaneve G, Micozzi A, Gentile G, Furno P, Russo D, D'Antonio D, Ricci P, Martino B, Mandelli F. A multicenter, double blind, placebo controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis. 2001;33:1295-1301.
6. Diekema DJ, Pfaller MA, Jones RN; SENTRY Participants Group. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000. Int J Antimicrob Agents. 2002;20:412-418.
7. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med. 1990;89:137-141.
8. Fowler VG Jr, Justice A, Peacock S-J. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695-703.
9. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066-2072.
10. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478-486.
11. Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003;21:4194-4199.
12. Gopal AK, Fowler VG Jr, Shah M, Gesty-Palmer D, Marr KA, McClelland RS, Kong LK, Gottlieb GS, Lanclos K, Li J, Sexton DJ, Corey GR. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol. 2000;18:1110-1115.
13. Jernigan JA, Farr BM. Short course therapy of catheter-related Staphylococcus aureus bacteremia: a meta analysis. Ann Intern Med. 1993;119:304-311.
14. Kim SH, Park WB, Choe KW. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus no eradicable foci. Clin Infect Dis. 2003;37:794-799.
15. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia: minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med. 1995;155:1161-1166.
16. Martin C, Viviand X, Saux P. Upper extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med. 1999;27:2626-2629.
17. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penades J, Litt D, Fitzgerald DJ, Foster TJ, Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors Clf A and Clf B, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol. 2002;44:1033-1044.
18. Raad I, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994;271:1014-1016.
19. Raad I, Narro J, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis. 1992;11:675-682.
20. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis. 2004;39:S25-S31.
21. Rubio M, Palau L, Vivas JR, Del Potro E, Diaz-Mediavilla J, Alvarez A, Martinez R, Picazo JJ. Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol. 1994;15:101-104.
22. Vanholder R, De Smet R, Jacobs V, Van Landschoot N, Waterloos MA, Vogeleere P, Ringoir S. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. Nephrol Dial Transplant. 1994;9:1271-1278.
23. Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Goncalves VM. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004;10:542-549.
24. Venditti M, Falcone M, Micozzi A, Carfagna P, Taglietti F, Serra PF, Martino P. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica. 2003;88:923-930.
25. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665-3675.
26. Wisplinghoff H, Bischoff T, Tallent MS, Harald S, Wenzel R, Edmond MB. Nosocomial blood stream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-317.
27. Wisplinghoff H, Seifer H, Wenzel R, Edmond M. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36:1103-1110.
28. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and -resistant bacteria. Clin Infect Dis. 1999;29:490-494.